Effect of Sn doping on the structural, photoluminescence, ultraviolet filtering and antibacterial activity of ZnO nanorods

In the present study, Sn-doped ZnO nanorods with varying Sn concentrations (0.5%, 1%, 2% and 5%) were prepared by wet chemical route. XPS results demonstrate the occurrence of doublet binding energies at 487.21 eV and 495.60 eV for the 5% Sn-doped ZnO nanorods which indicate the effective incorporat...

Full description

Saved in:
Bibliographic Details
Published in:Optical and quantum electronics Vol. 55; no. 12
Main Authors: Singh, C. John Clement, Samuel, J., Biju, C. S., Dhas, S. Sahaya Jude, Usharani, S.
Format: Journal Article
Language:English
Published: New York Springer US 01-11-2023
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the present study, Sn-doped ZnO nanorods with varying Sn concentrations (0.5%, 1%, 2% and 5%) were prepared by wet chemical route. XPS results demonstrate the occurrence of doublet binding energies at 487.21 eV and 495.60 eV for the 5% Sn-doped ZnO nanorods which indicate the effective incorporation of Sn in the ZnO. Raman measurements reveal that the substitution of Sn 4+ ions with the Zn 2+ ions modifies the spectral lines associated with the E2H–E2L and A1 (LO) modes. The photoluminescence measurement of 5% Sn-doped ZnO reveals that the observed polychromatic emissions in the UV–visible regime have comparatively higher intensity than the other samples. interestingly, the 5% Sn-doped ZnO nanorods impart a positive UV filtering execution of 95% for UVA at 360 nm and 91% for UVB at 320 nm and the observed results of UV–visible absorbance have the ingredients of being a promising material for the preparation of sunscreen agents. Besides these intriguing results, the material could also throw a positive antibacterial effect for S. aureus such that among the four materials tested, 5% Sn-doped ZnO exhibits the highest zone of inhibition (12 ± 0.58) for S. aureus .
ISSN:0306-8919
1572-817X
DOI:10.1007/s11082-023-05336-0